Invest now

Natural Capsules share price

High risk
  • 63%Low risk
  • 63%Moderate risk
  • 63%Balanced risk
  • 63%High risk
  • 63%Extreme risk
  • 188.50(-1.72%)
    September 11, 2026 15:56:42 PM IST
    • NSE
    • BSE
  • Vol : 9.94 K (NSE + BSE)
    Last 20 day avg : 52.90 K
Natural Capsules is trading -1.72% lower at Rs 188.50 as compared to its last closing price. Natural Capsules has been trading in the price range of 189.60 & 185.75. Natural Capsules has given 14.09% in this year & -12.49% in the last 5 days. The company posted a net profit of -3.98 Crores in its last quarter.Listed peers of Natural Capsules include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in Natural Capsules was at -% in . The MF holding has - from the last quarter. The FII holding in Natural Capsules was at -% in . The FII holding has - from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 14 Sep 2026, 05:21 PM IST

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.50
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.13
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
185.75
Highest
189.60
52 week range
Lowest
137.50
Highest
296.40
Natural Capsules Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
1,842.00-1.184,41,947.0938.405.550.830.47
Divi's Laboratories
9,326.00-0.842,47,576.0073.3211.480.410.03
Torrent Pharmaceuticals
4,975.000.951,89,226.2472.7319.220.80141.16
Cipla
1,365.00-1.091,10,191.9527.573.330.921.11
Zydus Lifesciences
1,119.500.131,11,670.5521.194.240.0914.22
Natural Capsules Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-09-02Preferential issue of shares
2026-08-12Quarterly Results & Pref. issue
2026-05-27Audited Results
2026-02-13Quarterly Results
2025-11-13Quarterly Results
About the company Natural Capsules
  • IndustryBiotechnology & Drugs
  • ISININE936B01015
  • BSE Code524654
  • NSE CodeNATCAPSUQ
Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in manufacturing an array of capsules, including hard gelatin capsules, vegetarian capsules, and various specialty variants. The Company offers a diverse range of capsule products to both domestic and international markets, serving the pharmaceutical and nutraceutical industries. Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. It has two manufacturing facilities that are located in Bengaluru and Puducherry.
  • Management Info
  • Prasanna JunnarkarChief Financial Officer
  • Sunil MundraManaging Director, Executive Director
  • Laxminarayan MoondraWhole-time Director
  • Satyanarayan MundraWhole-Time Director
Natural Capsules Share Price FAQs

Natural Capsules is trading at 188.50 as on Fri Sep 11 2026 10:26:42. This is -1.72% lower as compared to its previous closing price of 191.80.

The market capitalization of Natural Capsules is 196.25 Cr as on Fri Sep 11 2026 10:26:42.

The 52 wk high for Natural Capsules is 296.40 whereas the 52 wk low is 137.50

Natural Capsules can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 36.32
  • Dividend Yield: 0.00%
  • D/E ratio: -

Natural Capsules reported a net profit of -17.07 Cr in 2026.